|
1
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Botter SM, Neri D and Fuchs B: Recent
advances in osteosarcoma. Curr Opin Pharmacol. 16:15–23. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment-where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu C and Jiang DL: Expression of POSTN
mRNA is associated with osteosarcoma prognosis. Int J Clin Exp
Pathol. 9:10664–10669. 2016.
|
|
5
|
Li J, Liu L, Li J, Chen Y, Jiang XW,
Ouyang YR, Liu YQ, Zhong H, Li H and Xiao T: Microarray expression
profile of long noncoding RNAs in human osteosarcoma. Biochem
Biophys Res Commun. 433:200–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hay N: Reprogramming glucose metabolism in
cancer: Can it be exploited for cancer therapy? Nat Rev Cancer.
16:635–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang X, Wang CC, Lee WYW, Trovik J, Chung
TKH and Kwong J: Long non-coding RNA HAND2-AS1 inhibits invasion
and metastasis in endometrioid endometrial carcinoma through
inactivating neuromedin U. Cancer Lett. 413:23–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng X, Han H, Liu GP, Ma YX, Pan RL,
Sang LJ, Li RH, Yang LJ, Marks JR, Wang W and Lin A: LncRNA wires
up Hippo and Hedgehog signaling to reprogramme glucose metabolism.
EMBO J. 36:3325–3335. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boroughs LK and DeBerardinis RJ: Metabolic
pathways promoting cancer cell survival and growth. Nat Cell Biol.
17:351–359. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kong D and Wang Y: Knockdown of lncRNA
HULC inhibits proliferation, migration, invasion and promotes
apoptosis by sponging miR-122 in osteosarcoma. J Cell Biochem.
119:1050–1061. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu Y, Yang Q, Wang L, Wang S, Sun F, Xu D
and Jiang J: Knockdown of the oncogene LncRNA NEAT1 restores the
availability of miR-34c and improves the sensitivity to
cisplatin in osteosarcoma. Biosci Rep. 38(pii): BSR201803752018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y and Kong D: LncRNA GAS5 represses
osteosarcoma cells growth and metastasis via sponging miR-203a.
Cell Physiol Biochem. 45:844–855. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawashima M, Yamamura M, Taniai M,
Yamauchi H, Tanimoto T, Kurimoto M, Miyawaki S, Amano T, Takeuchi T
and Makino H: Levels of interleukin-18 and its binding inhibitors
in the blood circulation of patients with adult-onset Still's
disease. Arthritis Rheum. 44:550–560. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yaman Agaoglu F, Kovancilar M, Dizdar Y,
Darendeliler E, Holdenrieder S, Dalay N and Gezer U: Investigation
of miR-21, miR-141 and miR-221 in blood circulation of patients
with prostate cancer. Tumour Biol. 32:583–588. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sabbisetti VS, Waikar SS, Antoine DJ,
Smiles A, Wang C, Ravisankar A, Ito K, Sharma S, Ramadesikan S, Lee
M, et al: Blood kidney injury molecule-1 is a biomarker of acute
and chronic kidney injury and predicts progression to ESRD in type
I diabetes. J Am Soc Nephrol. 25:2177–2186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao M, Zhou Y, Zhu B, Wan M, Jiang T, Tan
Q, Liu Y, Jiang J, Luo S, Tan Y, et al: IFI44L promoter methylation
as a blood biomarker for systemic lupus erythematosus. Ann Rheum
Dis. 75:1998–2006. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kunkel M, Reichert TE, Benz P, Lehr HA,
Jeong JH, Wieand S, Bartenstein P, Wagner W and Whiteside TL:
Overexpression of Glut-1 and increased glucose metabolism in tumors
are associated with a poor prognosis in patients with oral squamous
cell carcinoma. Cancer. 97:1015–1024. 2003. View Article : Google Scholar : PubMed/NCBI
|
